Several rare gene fusions involving PDGFRβ have been described in patients with chronic myeloproliferative disorders (MPD), myelodysplastic/myeloproliferative syndromes (MDS/MPD) and AML [1]. Here, PDGFRB is linked to myeloproliferative disorder.